Distribution on the pharmaceutical market in Poland 2010

The aim of the report is to provide the complex analysis of the distribution on the pharmaceutical market in Poland. It focuses on the analysis of the main market segments i.e.:

• pharmacy distribution
• non-pharmacy distribution
• hospital distribution

providing segments’ characteristic and profiles of leading players in each segment. Direct distribution and exclusive distribution are also analysed, as well as parallel imports and exports.

Moreover, the report presents the results of a unique survey carried out by PMR among leading pharmaceutical companies on the Polish pharmaceutical market.

Distribution on the pharmaceutical market in Poland 2010, Development forecasts for 2010-2012 provides feedback from industry insiders directly from a new PMR market survey, as well as solid forecasting that focuses on how pharmaceutical product makes its way into the hands of Polish consumers during the next two years.

Request sample pages/interactive screenshare

To receive more information on this report, please sign up.

*required

*Would you like a FREE interactive screenshare?		Yes No
*Email:
		To make sure you receive the requested information, add info@pmrcorporate.com to your company trusted emails. Contact your IT department for details.
*Your company core business:		IT, Telecoms Construction Pharma, Healthcare Retail, FMCG Finance, Investments Consulting, Research, Law Government, Trade Organisations Media, Publications Education, Students Other
		Privacy Policy
		I agree with terms and conditions of PMR Privacy Policy. SUBSCRIBE

1. Report methodology

2. Executive summary

3. Overview of distribution on the pharmaceutical market in Poland in the years 2005-2012

   • Key events and trends in the years 2008-2009
   • Expected events and trends in the years 2010-2012
   • Value of various distribution channels in the years 2005-2012
     • Share of various distribution channels in market value
     • The pharmacy distribution market
     • The hospital distribution market

4. Pharmacy distribution

   • Wholesale distribution
     • Numbers and types of wholesalers
     • Concentration of wholesalers on the pharmacy market
     • The largest players on the pharmacy market
     • Full-line distribution
       • Profile of the model
       • Profiles of selected leading players
     • Short-line distribution
       • Profile of the model
       • Profiles of selected leading players
   • Pharmacy distribution
     • Number of pharmacies
     • Financial condition of pharmacies
     • Customer numbers in pharmacies
     • Pharmacy cooperation with wholesalers
     • Pharmacy chains
       • Pharmacy chains with connections to wholesalers
         • Profiles of selected leading players
       • Independent pharmacy chains
         • Chains of over 20 pharmacies
           • Profiles of selected leading players
         • Pharmacy chains numbering 10-20 outlets
           • Profiles of selected leading players
         • Pharmacy chains of fewer than 10 outlets
           • Profiles of selected leading players
     • Pharmacy franchise chains
     • Pharmacy buying groups
     • Pharmacy points
     • Internet pharmacies
       • Profile of the segment
       • The internet pharmacy as a place to buy drugs
       • Number of internet pharmacies
       • Leading internet pharmacies
         • Profiles of selected leading players

5. Non-pharmacy distribution

   • Profile of the segment
   • Advertising of OTC drugs in retail chains’ magazines
   • Entities distributing drugs via the non-pharmacy channel
   • Wholesale distribution
     • Profiles of selected leading players specialising in non-pharmacy distribution
   • Retail distribution
     • General stores
       • Hypermarkets
       • Supermarkets
       • Discount stores
       • Small grocery stores
       • Convenience stores
       • Shops at petrol stations
     • Kiosks
     • Cosmetics/drugstores
     • Herbal/medical shops

6. Hospital distribution

   • Profile of the segment
   • The financial condition of hospitals in Poland
   • Biggest players on the hospital market
     • Profiles of selected leading players

7. Direct, DTP and exclusive distribution

   • Key features of the models
   • The legal environment
   • Examples of manufacturers using direct distributin or DTP on the Polish market

8. Parallel trade

   • Parallel import
     • Legal environment
     • Number of parallel import permits
     • Market size
     • Reimbursement of parallel import drugs
     • Biggest players on the parallel imports market
       • Profiles of leading players
   • Parallel export

9. Results of the survey conducted among the largest pharmaceutical companies in Poland

   • Development of distribution channels on the pharmaceutical market
     • Internet sales
     • Sales in general stores
     • Direct distribution
     • Exclusive distribution
   • Other services rendered by distributors
   • Expected impact of legal changes on the pharmaceutical market

10. Annex 1

    • List of drugs approved for sale in general stores

11. List of graphs

12. List of tables

13. About PMR

14. Contact PMR

List of graphs

1. Place where Poles buy medical supplies, 2008
2. Revenues and net result (PLN m) of CF Cefarm in Poland, 2007-2008
3. Estimated shares of various distribution channels in the pharmaceutical market in Poland, 2009
4. Value (PLN bn) and dynamics of the pharmacy market in Poland, 2005-2012
5. Value (PLN bn) and dynamics of the hospital drugs market in Poland, 2005-2012
6. Location of pharmaceutical wholesalers’ warehouses in Poland, by voivodship, November 2009
7. Number of pharmaceutical wholesalers’ warehouses with licences for trade in specific ranges of medical products, by type of products sold, November 2009
8. Market shares of the 10 largest wholesalers on the pharmacy market in Poland, 1994-Q2 2009
9. Shares of wholesale groups in distribution to pharmacies in Poland, Q2 2009
10. Market shares of largest players on the pharmaceutical wholesale market in Poland, by sales to pharmacies, Q3 2009
11. Full-line distribution model in Poland, 2010
12. The Torfarm group’s wholesale logistics structure in Poland, 2009
13. Torfarm group sales revenues (PLN m) and their dynamics in Poland, 2003-Q3 2009
14. Torfarm group net profits (PLN m) and their dynamics in Poland, 2003-Q3 2009
15. Torfarm group sales structure, breakdown by dependent companies, Q1-3 2009
16. Structure of the PGF capital group, 2009
17. The PGF group’s wholesale logistics structure in Poland, 2009
18. PGF group sales revenues (PLN m) and their dynamics, 2001-Q3 2009
19. PGF group net profits (PLN m) and their dynamics, 2001-Q3 2009
20. Sales structure of the PGF group, Q1-Q3 2009
21. The Farmacol group’s wholesale logistics structure in Poland, 2009
22. Farmacol sales revenues (PLN m) and their dynamics in Poland, 2004-Q3 2009
23. Farmacol group net profits (PLN m) and their dynamics in Poland, 2004-Q3 2009
24. Revenues and net profits (PLN m) of Cefarm Bialystok in Poland, 2004-2008
25. Mediq group structure, 2009
26. The ACP Pharma wholesale distribution logistics structure in Poland, 2009
27. ACP Pharma wholesale revenues in Poland (€ m) and their dynamics, 2005-Q3 2009
28. ACP Pharma sales structure in Poland, Q3 2009
29. The Phoenix Pharma wholesale distribution logistics structure in Poland, 2009
30. Phoenix Pharma sales revenues (PLN m) in Poland and their dynamics, 2004/2005-2008/2009
31. Net result (PLN m) of Phoenix Pharma in Poland, 2004/2005-2008/2009
32. OPDF shareholder structure in Poland, 2009
33. The Hurtap wholesale distribution logistics structure in Poland, 2009
34. Hurtap sales revenues (PLN m) and their dynamics in Poland, 2003-2008
35. Hurtap’s net profits (PLN m) and their dynamics in Poland, 2003-2008
36. Multi Pharme revenues and net profits (PLN m) in Poland, 2004-2008
37. Intra sales revenues (PLN m) and their dynamics in Poland, 2003-2008
38. Intra’s net profits (PLN m) and their dynamics in Poland, 2003-2008
39. Medicare sales revenues (PLN m) and their dynamics in Poland, 2003-2007
40. Medicare net profits (PLN m) and their dynamics in Poland, 2003-2007
41. Lubfarm revenues (PLN m) in Poland and their dynamics, 2003-2007
42. Lubfarm net profits (PLN m) in Poland and their dynamics, 2003-2007
43. Preska sales revenues (PLN m) in Poland and their dynamics, 2003-2007
44. Preska net result (PLN ‘000) in Poland and their dynamics, 2003-2007
45. Salus International sales revenues (PLN m) in Poland and their dynamics, 2002-2008
46. Salus International net profits (PLN m) in Poland and their dynamics, 2002-2008
47. Short-line distribution model in Poland, 2010
48. Pretium Farm revenues (PLN m) in Poland and their dynamics, 2006-Q3 2009
49. Estimated sales structure of Pretium Farm in Poland, 2009
50. Number of pharmacy outlets in Poland, by type, December 2009
51. Number of pharmacy outlets in Poland, by voivodship, December 2009
52. Number of residents per pharmacy outlet in Poland, by voivodship, December 2009
53. Average monthly revenues of pharmacies (PLN ‘000) and their dynamics in Poland, January-November 2009
54. Average numbers of customers to pharmacies (‘000) in Poland, January-November 2009
55. Number of pharmacies belonging to pharmacy chains in Poland, Q2 2009
56. Largest pharmacy chains owned by pharmaceutical wholesalers in Poland, Q3 2009
57. Pharmacies belonging to Farmacol in Poland, by name, December 2009
58. Pharmacies belonging to ACP Pharma in Poland, by name, Q3 2009
59. ACP Pharma retail sales revenues in Poland (€ m) and their dynamics, 2005-Q3 2009
60. Selected largest independent pharmacy chains in Poland (no. of outlets), with over 20 outlets, December 2009
61. Revenues and net result of  xxx in Poland (PLN m), 2004-2008
62. Revenues and net result of xxx in Poland (PLN m), 2003-2007
63. Pharmacies in the xxxchain (no. of outlets according to proprietor) in Poland, December 2009
64. xxx sales revenues in Poland (PLN m), 2006-2007
65. Revenues and net result of xxx in Poland (PLN m), 2004-2008
66. Selected largest independent pharmacy chains in Poland (no. of outlets), 10-20 outlets, December 2009
67. Revenues and net profit of xxx in Poland (PLN m), 2004-2008
68. Revenues and net profit of xxx in Poland (PLN m), 2004-2008
69. Revenues and net profit of xxx in Poland (PLN m), 2004-2007
70. Pharmacies in the xxx chain (no. of outlets by proprietor) in Poland, December 2009
71. Revenues and net profits of xxx in Poland (PLN m), 2003-2007
72. Revenues and net profit of xxx in Poland (PLN m), 2004-2008
73. Selected largest independent pharmacy chains in Poland (no. of outlets), 7-9 outlets, December 2009
74. Selected largest independent pharmacy chains in Poland (no. of outlets), 5-6 outlets, December 2009
75. Pharmacies belonging to the xxx in Poland, December 2009
76. Revenues and net profit of xxx in Poland (PLN m), 2004-2008
77. Revenues and net profit of xxx in Poland (PLN m), 2005-2008
78. Revenues and net profit of xxx in Poland (PLN m), 2003-2007
79. Pharmacies owned by xxx in Poland, December 2009
80. Revenues of xxx and xxx in Poland (PLN m), 2006-2008
81. Most popular internet pharmacies in Poland, by numbers of real users, October 2009
82. Comparison of user numbers (real users) of the most popular internet pharmacies in Poland, Q1 2008, December 2008 and October 2009
83. Most popular internet pharmacies in Poland by numbers of hits, October 2009
84. Most popular internet pharmacies in Poland by numbers of hit per user, October 2009
85. Most popular internet pharmacies in Poland by average time spent per user (h: min: s), October 2009
86. Most popular internet pharmacies in Poland by penetration among internet users, October 2009
87. Sales revenues and net financial result of DomZdrowia.pl in Poland (PLN ‘000), 2007-Q3 2009
88. Number of promotions of OTC drugs in magazines of drugstore and retail chains in Poland, 1st-37th weeks of 2007 and 2008
89. Non-pharmacy distribution model in Poland, 2010
90. xxx pharmaceutical distribution structure in Poland, December 2009
91. xxx pharmaceutical distribution structure in Poland, December 2009
92. xxx pharmaceutical distribution structure in Poland, December 2009
93. xxx pharmaceutical distribution structure in Poland, December 2009
94. xxx pharmaceutical distribution structure in Poland, December 2009
95. Shares of various retail formats in the grocery market in Poland, by sales, 2009
96. Share of various store formats in non-pharmacy sales of OTC drugs, by value, December 2008-November 2009
97. Sales structure of OTC products in hypermarkets in Poland, by value, December 2008-November 2009
98. Sales structure of OTC products in supermarkets in Poland, by value, December 2008-November 2009
99. Sales structure of OTC products in small-format stores (area of 101-300 m2) in Poland, by value, December 2008-November 2009
100. Sales structure of OTC products in small-format stores (area of 40-100 m2) in Poland, by value, December 2008-November 2009
101. Sales structure of OTC products in small-format stores (area of under 40 m2) in Poland, by value, December 2008-November 2009
102. No. of petrol stations owned by the major fuel concerns in Poland, Q3 2009
103. Sales structure of OTC products in shops at petrol stations in Poland, by value, December 2008-November 2009
104. Estimated number of kiosks in the chains of the largest press distributors in Poland, Q3 2009
105. Sales structure of OTC products in kiosks in Poland, by value, December 2008-November 2009
106. Selected largest cosmetics/drugstore chains in Poland (no. of stores), December 2009
107. Drug distribution model on the hospital market in Poland, 2010
108. Enforceable debt of SP ZOZ in Poland (PLN bn), Q1 2005-Q3 2009
109. Total debt of SP ZOZ in Poland (PLN bn), Q1 2005-Q3 2009
110. Wholesale groups’ shares in distribution to hospitals in Poland, Q2 2009
111. Sales to hospitals compared to total sales revenues of PGF (PLN m) in Poland, 2007-Q3 2009
112. Revenues and net profits of xxx in Poland (PLN m), 2001-2008
113. Value of xxx sales of selected drugs offered to the hospital segment (PLN m) in Poland, 2005-2006
114. Revenues and net profit of xxx in Poland (PLN m), 1999-2008
115. Revenues and net profit of xxx in Poland (PLN m), 2006-2008
116. DTP (direct-to-pharmacy) distribution model in Poland, 2010
117. Direct distribution model in Poland, 2010
118. Wholesale distribution channels of dermocosmetics in Poland, 2008
119. Distribution models on the dermocosmetics market in Poland, October 2008
120. No. of applications submitted and no. of parallel import permits issued in Poland, 2004-August 2009
121. Countries of origin of drugs imported to Poland as parallel imports, by no. of permits, 2009
122. Sales value of parallel import drugs in Poland (PLN m), Q1 2006-Q4 2009
123. No. of packets of parallel import drugs sold in Poland (million), Q1 2008-Q3 2009
124. The Polish market of parallel importers, by numbers of permits, 2009
125. Revenues and net profit (PLN m) of xxx in Poland, 2005-H1 2009
126. Revenues and net profit (PLN m) of xxx in Poland, 2008-May 2009
127. Revenues and net profit (PLN m) of xxx in Poland, 2004-2008
128. Revenues and net profit (PLN m) of xxx in Poland, 2007-2008
129. Average manufacturer price (MSRP) per comparable drug unit in Poland and other European countries, 2008
130. Evaluation of the sales development dynamic in various distribution channels compared to the overall market over the next 12 months in Poland, 2009
131. Best-selling product categories in the internet channel over the next two years in Poland, 2009
132. Product categories that will sell best in general stores over the next two years in Poland, 2009
133. Penetration and type of direct distribution used on the pharmaceutical market in Poland, 2009
134. Are you considering implementing direct distribution?, 2009
135. Comparison of revenues of firms not using and not planning to use direct distribution with whole-sample average, 2009
136. Do you currently use an exclusive distribution system?, 2009
137. Are you considering introducing exclusive distribution?, 2009
138. Reasons for not using the exclusive distribution model in Poland, 2009
139. Additional services offered by wholesalers and logistics operators most sought after by manufacturers in Poland, 2009
140. Evaluation of the impact of the planned introduction of fixed margins and prices of reimbursed drugs on various market players in Poland, 2009
141. Evaluation of the impact of the planned tightening up of anticoncentration rule on various market players in Poland, 2009

List of tables

1. Acquisitions by Torfarm in the wholesale segment in Poland, 2007-2009
2. Takeovers by PGF in the wholesale segment, 2007-2009
3. Takeovers by Farmacol in the wholesale segment in Poland, 2008-2009
4. Selected pharmacy takeovers by PGF in Poland, 2007-2008
5. Revenues and net financial result of selected pharmacies and pharmacy chains owned by xxx in Poland, 2007/2008
6. Revenues and net financial result of selected pharmacies and pharmacy chains owned by xxx in Poland, 2007/2008
7. Revenues and net financial result of selected pharmacies and pharmacy chains owned by xxx in Poland, 2007/2008
8. Revenues and net financial result of selected pharmacies and pharmacy chains owned by xxx in Poland, 2007/2008
9. Revenues and net financial result of selected pharmacies and pharmacy chains belonging to xxx in Poland, 2007/2008
10. Revenues and net financial result of selected pharmacies and pharmacy chains belonging to xxx in Poland, 2007
11. Revenues and net financial result of selected pharmacies and pharmacy chains belonging to xxx in Poland, 2007
12. Internet pharmacies operating in Poland, December 2009
13. Comparison of delivery terms of selected internet pharmacies in Poland, December 2009
14. Hypermarket chains in Poland by value of sales and number of outlets, 2008 and 2009
15. Largest supermarket chains in Poland by value of sales and no. of stores, 2008 and 2009
16. Discount chains in Poland by value of sales and no. of stores, 2008 and 2009
17. Largest chains of small grocery stores in Poland by value of sales and number of stores, 2008 and 2009
18. Largest convenience store chains in Poland, by value of sales and no. of stores, 2008 and 2009
19. Herbal/medical shops in Poland by voivodship, 2008
20. Comparison of direct distribution and traditional distribution models on the pharmaceutical market, 2009
21. Comparison of the wording of the Pharmaceutical Law and Directive in the area of fulfilling supply obligations
22. Parallel import drugs eligible for reimbursement in Poland, 2009
23. Manufacturers and countries of origin of drugs imported by xxx as parallel imports to Poland, 2009
24. Manufacturers and countries of origin of drugs imported by xxx as parallel imports to Poland, 2009
25. Manufacturers and countries of origin of drugs imported by xxx as parallel imports to Poland, 2009
26. Manufacturers and countries of origin of drugs imported by xxx as parallel imports to Poland, 2009
27. Extent to which direct distribution is used in Poland, 2009
28. List of drugs approved for sales in general stores in Poland, October 2009